EuroAPI Logo

EuroAPI

Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

EuroAPI is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs). Spun off from Sanofi, the company leverages a unique European industrial network of six production sites to serve healthcare partners in over 80 countries. It offers one of the industry's largest portfolios, with approximately 200 APIs for human and animal health, and holds a leading position in small molecules. In addition to its extensive API catalog, EuroAPI provides Contract Development and Manufacturing Organization (CDMO) services for innovative companies, developing and producing more complex molecules. The company is focused on reliability, high-quality production standards, and regulatory compliance.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 17:45
Regulatory News Service
Avec Med4Cure, EUROAPI accélère l’innovation pharmaceutique au service de la so…
French 750.3 KB
2025-10-23 17:45
Regulatory News Service
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of …
English 748.2 KB
2025-09-30 17:45
Board/Management Information
Evolution de la composition du Conseil d’administration
French 535.7 KB
2025-09-30 17:45
Board/Management Information
Change in Board’s Composition
English 537.6 KB
2025-07-31 18:30
Report Publication Announcement
Mise à disposition du Rapport financier semestriel 2025
French 444.9 KB
2025-07-31 18:30
Report Publication Announcement
Availability of 2025 Half-Year Financial Report
English 442.4 KB
2025-06-30 17:58
M&A Activity
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de …
French 531.0 KB
2025-06-30 17:58
M&A Activity
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 trans…
English 704.7 KB
2025-06-17 17:02
Major Shareholding Notification
Franchissement de seuils
French 124.2 KB
2025-06-17 16:46
Major Shareholding Notification
Franchissement de seuils
French 104.6 KB
2025-06-04 17:45
Board/Management Information
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Sol…
English 704.4 KB
2025-06-04 17:45
Board/Management Information
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des ac…
French 529.1 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Assemblée Générale Mixte du 21 mai 2025
French 522.9 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Combined General Meeting of May 21, 2025
English 722.2 KB
2025-04-29 17:40
Pre-Annual General Meeting Information
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de…
French 500.7 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuroAPI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America APRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.